Publication Cover
Stress
The International Journal on the Biology of Stress
Volume 10, 2007 - Issue 2
643
Views
53
CrossRef citations to date
0
Altmetric
Original

Negative regulation of corticotropin releasing factor expression and limitation of stress response

, , &
Pages 153-161 | Received 21 Feb 2007, Accepted 06 Apr 2007, Published online: 07 Jul 2009

References

  • Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 1994; 15: 321–350
  • Aguilera G. Corticotropin releasing hormone, receptor regulation and the stress response. TEM 1998; 9: 329–336
  • Aguilera G, Nikodemova M, Wynn PC, Catt KJ. Corticotropin releasing hormone receptors: Two decades later. Peptides 2004; 25: 319–329
  • Bale TL, Vale WW. CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004; 44: 525–557
  • Borsook D, Smirnova O, Behar O, Lewis S, Kobierski LA. PhosphoCREB and CREM/ICER: Positive and negative regulation of proenkephalin gene expression in the paraventricular nucleus of the hypothalamus. J Mol Neurosci 1999; 12: 35–51
  • Canny BJ, Funder JW, Clarke IJ. Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress-specific manner. Endocrinology 1989; 125: 2532–2539
  • Collins S, Lohse MJ, O'Dowd B, Caron MG, Lefkowitz RJ. Structure and regulation of G protein-coupled receptors: The beta 2-adrenergic receptor as a model. Vitam Horm 1991; 46: 1–39
  • Cooper DMF, Mons N, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 1995; 374: 421–424
  • Dallman MF, Akana SF, Levin N, Walker C-D, Bradbury MJ, Suemaru S, Scribner KS. Corticosteroids and the control of function in the hypothalamo-pituitary–adrenal (HPA) axis. Ann N Y Acad Sci 1994; 746: 22–28
  • Day HEW, Campeau S, Watson SJ, Jr., Akil H. Expression of alpha 1b adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J Neurosci 1999; 19: 10098–10106
  • de Goeij DC, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJ. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. Neuroendocrinology 1991; 53: 150–159
  • de Kloet ER, Joels M, Holsboer F. Stress and the brain: From adaptation to disease. Nat Rev Neurosci 2005; 6: 463–475
  • Fenoglio KA, Brunson KL, Avishai-Eliner S, Chen Y, Baram TZ. Region-specific onset of handling-induced changes in corticotropin-releasing factor and glucocorticoid receptor expression. Endocrinology 2004; 145: 2702–2706
  • Feuvrier E, Aubert M, Mausset AL, Alonso G, Gaillet S, Malaval F, Szafarczyk A. Glucocorticoids provoke a shift from alpha2- to alpha1-adrenoreceptor activities in cultured hypothalamic slices leading to opposite noradrenaline effect on corticotropin-releasing hormone release. J Neurochem 1998; 70: 1199–1209
  • Foulkes NS, Borrelli E, Sassone-Corsi P. CREM gene: Use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 1991; 64: 739–749
  • Foulkes NS, Borjigin J, Snyder SH, Sassone-Corsi P. Transcriptional control of circadian hormone synthesis via the CREM feedback loop. Proc Natl Acad Sci USA 1996; 93: 14140–14145
  • Guardiola-Diaz HM, Kolinske JS, Gates LH, Seasholtz AF. Negative glucorticoid regulation of cyclic adenosine 3′, 5′-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol Endocrinol 1996; 10: 317–329
  • Guarino RD, Perez DM, Piascik MT. Recent advances in the molecular pharmacology of the [alpha]1-adrenergic receptors. Cell Signal 1996; 8: 323–333
  • Harbuz MS, Lightman SL. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin A messenger RNA. Neuropeptides 1989; 14: 17–20
  • Heinrichs SC, Koob GF. Corticotropin-releasing factor in brain: A role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 2004; 311: 427–440
  • Herman JP, Cullinan WE. Neurocircuitry of stress: Central control of the hypothalamo-pituitary–adrenocortical axis. Trends Neurosci 1997; 20: 78–84
  • Herman JP, Schafer MK, Thompson RC, Watson SJ. Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. Mol Endocrinol 1992; 6: 1061–1069
  • Kovacs KJ, Sawchenko PE. Regulation of stress-induced transcriptional changes in the hypothalamic neurosecretory neurons. J Mol Neurosci 1996; 7: 125–133
  • Kovacs K, Kiss JZ, Makara GB. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 1986; 44: 229–234
  • Lamas M, Monaco L, Zazopoulos E, Lalli E, Tamai K, Penna L, Mazzucchelli C, Nantel F, Foulkes NS, Sassone-Corsi P. CREM: A master-switch in the transcriptional response to cAMP. Philos Trans R Soc Lond B Biol Sci 1996; 351: 561–567
  • Lightman SL, Young WS. Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress. Proc Natl Acad Sci USA 1989; 86: 4306–4310
  • Liposits Z, Paull WK, Setalo G, Vigh S. Evidence for local corticotropin releasing factor (CRF) immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunocytochemical analysis. Histochemistry 1985; 83: 5–16
  • Liposits Z, Uht RM, Harrison RW, Gibbs FP, Paull WK, Bohn MC. Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF). Histochemistry 1987; 87: 407–412
  • Lui Y, Aguilera G. Increases in endogenous CAMP inducible early repressor (ICER) inhibit corticot-ropin releasing hormone transcription in hypothalamic, 4B, cells and inprimary hypothalamic cell cultures. 2006, The Endocrine Society 88th Annnual Meeting, 2006, p 171, abst
  • Liu Y, Kalintchenko N, Sassone-Corsi P, Aguilera G. Inhibition of corticotrophin-releasing hormone transcription by inducible cAMP-early repressor in the hypothalamic cell line, 4B. J Neuroendocrinol 2006; 18: 42–49
  • Lolait SJ, Stewart LQ, Jessop DS, Young WS, 3rd, O'Carroll AM. The hypothalamic–pituitary–adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 2007; 148: 849–856
  • Luo X, Kiss A, Makara G, Lolait SJ, Aguilera G. Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol 1994; 6: 689–696
  • Ma XM, Levy A, Lightman SL. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: A study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA. Endocrinology 1997; 138: 4351–4357
  • Ma XM, Aguilera G. Differential regulation of corticotropin-releasing hormone and vasopressin transcription by glucocorticoids. Endocrinology 1999a; 140: 5642–5650
  • Ma XM, Aguilera G. Transcriptional responses of the vasopressin and corticotropin-releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection in rats. Brain Res Mol Brain Res 1999b; 68: 129–140
  • Ma XM, Lightman SL, Aguilera G. Vasopressin and corticotropin-releasing hormone gene responses to novel stress in rats adapted to repeated restraint. Endocrinology 1999; 140: 3623–3632
  • Makino S, Schulkin J, Smith MA, Pacak K, Palkovits M, Gold PW. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 1995; 136: 4517–4525
  • Malkowski SP, Handanos CM, Dorin RI. Localization of a negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol Cell Endocrinol 1997; 127: 189–199
  • McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171–179
  • Moldrich RX, Beart PM. Emerging signalling and protein interactions mediated via metabotropic glutamate receptors. Curr Drug Targets CNS Neurol Disord 2003; 2: 109–122
  • Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P. Inducibility and negative autoregulation of CREM: An alternative promoter directs the expression of ICER, an early response repressor. Cell 1993; 75: 875–886
  • Monaco L, Lamas M, Tamai K, Lalli E, Zazopoulos E, Penna L, Nantel F, Foulkes NS, Mazzucchelli C, Sassone-Corsi P. Coupling transcription to signaling pathways: cAMP and nuclear factor cAMP-responsive element modulator. Adv Second Messenger Phosphoprotein Res 1997; 31: 63–74
  • Muglia LJ, Bethin KE, Jacobson L, Vogt SK, Majzoub JA. Pituitary-adrenal axis regulation in CRH-deficient mice. Endocr Res 2000; 26: 1057–1066
  • Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrinol Rev 1984; 5: 25–44
  • Nicholson RC, King BR, Smith R. Complex regulatory interactions control CRH gene expression. Front Biosci 2004; 9: 32–39
  • Nikodemova M, Kasckow J, Liu H, Manganiello V, Aguilera G. Cyclic adenosine 3′,5′-monophosphate regulation of corticotropin-releasing hormone promoter activity in AtT-20 cells and in a transformed hypothalamic cell line. Endocrinology 2003; 144: 1292–1300
  • Pacak K, Palkovits M, Kvetnansky R, Matern P, Hart C, Kopin IJ, Goldstein DS. Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. Endocrinology 1995; 136: 4814–4819
  • Plotsky PM, Bruhn TO, Vale W. Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 1985; 117: 323–329
  • Raadsheer FC, Sluiter AA, Ravid R, Tilders FJ, Swaab DF. Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res 1993; 615: 50–62
  • Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994; 60: 436–444
  • Rivier CL, Plotsky PM. Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 1986; 48: 475–494
  • Sawchenko PE. Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res 1987; 403: 213–224
  • Seasholtz AF, Thompson RC, Douglass JO. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol Endocrinol 1988; 2: 1311–1319
  • Shepard JD, Liu Y, Sassone-Corsi P, Aguilera G. Role of glucocorticoids and cAMP-mediated repression in limiting corticotropin-releasing hormone transcription during stress. J Neurosci 2005; 25: 4073–4081
  • Smith NJ, Luttrell LM. Signal switching, crosstalk, and arrestin scaffolds: Novel G protein-coupled receptor signaling in cardiovascular disease. Hypertension 2006; 48: 173–179
  • Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998; 20: 1093–1102
  • Stiedl O, Meyer M, Jahn O, Ogren SO, Spiess J. Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear. J Pharmacol Exp Ther 2005; 312: 905–916
  • Tannahill LA, Sheward WJ, Robinson IC, Fink G. Corticotrophin-releasing factor-41, vasopressin and oxytocin release into hypophysial portal blood in the rat: Effects of electrical stimulation of the hypothalamus, amygdala and hippocampus. J Endocrinol 1991; 129: 99–107
  • Tanoue A, Ito S, Honda K, Oshikawa S, Kitagawa Y, Koshimizu TA, Mori T, Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic–pituitary–adrenal axis activity under both stress and resting conditions. J Clin Invest 2004; 113: 302–309
  • Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 1983; 39: 245–270
  • Whitnall MH. Major pro-vasopressin-expressing and pro-vasopressin-deficient subpopulations of corticotropin-releasing hormone neurons in normal rats. Differential distributions within the paraventricular nucleus. Neuroendocrinology 1988; 47: 176–180
  • Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 1993; 40: 573–629
  • Zelena D, Foldes A, Mergl Z, Barna I, Kovacs KJ, Makara GB. Effects of repeated restraint stress on hypothalamo-pituitary–adrenocortical function in vasopressin deficient Brattleboro rats. Brain Res Bull 2004; 63: 521–530

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.